Literature DB >> 7654319

Dissection of functional domains in Bcl-2 alpha by site-directed mutagenesis.

C Borner1, R Olivier, I Martinou, C Mattmann, J Tschopp, J C Martinou.   

Abstract

Bcl-2 alpha is a mitochondrial or perinuclear-associated oncoprotein that prolongs the life span of a variety of cell types by interfering with programmed cell death. How Bcl-2 confers cell survival is unknown, although antioxidant and antiprotease functions have been proposed. In addition, protein structures of Bcl-2 that are crucial for its survival activity are still ill-defined. Bcl-2 can occur as Bcl-2 alpha or Bcl-2 beta, two alternatively spliced forms which solely differ in their carboxyl termini. The finding that Bcl-2 alpha is active and membrane bound, but Bcl-2 beta is inactive and cytosolic, indicates that the carboxyl terminus contributes to the survival activity of Bcl-2. This region contains two subdomains, a domain X with unknown function and a hydrophobic stretch reported to mediate membrane association of Bcl-2 alpha. Recently Bcl-2-related proteins have been identified. These include Bax that heterodimerizes with Bcl-2 and, when overexpressed, counteracts Bcl-2. Bax contains two highly conserved regions of sequence homology with Bcl-2, referred to as Bcl-2 homology 1 and 2 (BH1 and BH2) domains. Site-directed mutagenesis studies have revealed that both domains are not only novel dimerization motifs for the interaction of Bax with Bcl-2 but also crucial for the survival activity of Bcl-2. Interestingly, the C-terminal end of BH2 encompasses the Bcl-2 alpha/beta splice site, as well as part of domain X in Bcl-2 alpha.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7654319     DOI: 10.1139/o94-062

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  3 in total

1.  Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints.

Authors:  S Conus; T Kaufmann; I Fellay; I Otter; T Rossé; C Borner
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

2.  Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.

Authors:  Hsei-Wei Wang; Tyson V Sharp; Andrew Koumi; Georgy Koentges; Chris Boshoff
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

Review 3.  Bioactive lipids and the control of Bax pro-apoptotic activity.

Authors:  V Mignard; L Lalier; F Paris; F M Vallette
Journal:  Cell Death Dis       Date:  2014-05-29       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.